Expedition Therapeutics is gearing up for a phase 2 trek with a $165 million series A that closed Oct. 9. The new funding ...
Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...
Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...
GoodRx reports over 5.6 million Americans live in "pulmonology deserts," lacking accessible lung care, mostly in the central ...
After another swing and a miss for AstraZeneca's Fasenra in chronic obstructive pulmonary disease (COPD), the company is pivoting to other options in its portfolio that might have potential to treat ...
"These emissions drive global warming, exacerbating the very respiratory conditions inhalers are meant to relieve," ...
The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals and Roche's combination therapy as a maintenance ...
Among adolescents, the presentation of obstructive sleep apnea syndrome (OSAS) mirrors many typical signs of a much more common age-related diagnosis — hyperactivity, decreased attention span and ...
AMSTERDAM, Sept. 29, 2025 /PRNewswire/ -- Kaia Health, a global leader in digital therapeutics for chronic disease management, today announced a new collaboration with MedImprove, a leading private ...
Researchers conducted a prospective randomized controlled trial in 74 patients with stage III-IV COPD and prior hospitalization to assess the safety and efficacy of using telemedicine for follow-up.
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback